Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering,...
Source: prnewswire.com